Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (30)

2023

  1. Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction

    Scientific Reports, Vol. 13, Núm. 1

  2. Making STRONGer the transition phase: personalized GDMT through NT-proBNP monitoring

    European heart journal

  3. Personalizing anti-inflammatory therapy in heart failure: A new way

    European Journal of Heart Failure

2022

  1. Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2170-2180

  3. Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2): a randomized clinical trial

    European Journal of Heart Failure, Vol. 24, Núm. 10, pp. 1816-1826

2021

  1. Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence

    Scientific Reports, Vol. 11, Núm. 1

  2. Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review

    Frontiers in Cardiovascular Medicine, Vol. 8

2020

  1. Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain

    Revista Espanola de Cardiologia, Vol. 73, Núm. 5, pp. 361-367

  2. Expert consensus statement on heart failure with reduced ejection fraction: beyond the guidelines

    Revista Espanola de Cardiologia Suplementos, Vol. 20, Núm. SB, pp. 1-46

  3. Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study

    ESC Heart Failure, Vol. 7, Núm. 2, pp. 559-566

  4. Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164

  5. Prognostic value of discharge heart rate in acute heart failure patients: More relevant in atrial fibrillation?

    IJC Heart and Vasculature, Vol. 26

2019

  1. Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure

    Current Heart Failure Reports, Vol. 16, Núm. 6, pp. 304-314

  2. Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes

    JACC: Basic to Translational Science, Vol. 4, Núm. 7, pp. 831-840

2018

  1. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial

    European Journal of Heart Failure, Vol. 20, Núm. 7, pp. 1128-1136

  2. Genetic Etiology for Alcohol-Induced Cardiac Toxicity

    Journal of the American College of Cardiology, Vol. 71, Núm. 20, pp. 2293-2302

2017

  1. La fracción de eyección intermedia no permite estratificar el riesgo de los pacientes hospitalizados por insuficiencia cardiaca

    Revista Espanola de Cardiologia, Vol. 70, Núm. 5, pp. 338-346

  2. Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure

    International Journal of Cardiology, Vol. 240, pp. 265-270

  3. Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: The AGTP II trial

    BMJ Open, Vol. 7, Núm. 8